Table 1.
Test substance | Contact time |
---|---|
AMC/DCBA lozenge | 1, 5 and 10 min |
Strepsils® Honey and Lemon lozenge, containing 0.6 mg AMC and 1.2 mg DCBA, dissolved in 4.5 mL of artificial saliva⁎ | |
| |
Placebo lozenge for AMC/DCBA experiments | 1 and 10 min |
Placebo lozenge, dissolved in 4.5 mL artificial saliva⁎ | |
| |
AMC/DCBA as free active substances | 1 and 10 min |
0.6 mg AMC and 1.2 mg DCBA dissolved in 4.5 mL artificial saliva⁎ | |
Hexylresorcinol lozenge | 1, 5 and 10 min |
Strepsils Extra Cherry lozenge, containing 2.4 mg hexylresorcinol and 4 mg menthol, dissolved in 4.5 mL of artificial saliva⁎ | |
| |
Placebo lozenge for hexylresorcinol experiments | 1 and 10 min |
Placebo lozenge, dissolved in 4.5 mL artificial saliva⁎ | |
| |
Hexylresorcinol as a free active substance | 1 and 10 min |
2.4 mg hexylresorcinol as a free active substance, dissolved in 4.5 mL artificial saliva⁎ | |
Positive control | 1 min |
Sodium hypochlorite, 1000 ppm (1500 ppm for the hexylresorcinol experiments) | |
Negative control | 10 min |
Dilution medium (MEM + 3 μg/mL trypsin for the PIV3 experiments and MEM + 5% fetal bovine serum for the CMV experiments) |
AMC, amylmetacresol; CMV, cytomegalovirus; DCBA, 2,4-dichlorobenzyl alcohol; MEM, minimum essential medium; PIV3, parainfluenza virus type 3.
4.2 g sodium bicarbonate, 0.5 g sodium chloride, and 0.2 g potassium carbonate was added to ∼900 mL of sterile deionized water. 3 g of bovine serum albumin was added to the solution and the pH adjusted to 6.5 ± 0.5. Sterile deionized water was added to reach a total volume of 1000 mL.